Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nuvessa (Product 55394) in Bacterial Vaginosis
NCT01621399Phase 3Completed
- Sponsor
- Medicis Pharmaceutical
- Start
- May 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bacterial vaginosis (BV) comparing Product 55394 with Vehicle (2 arms). Primary endpoint: Clinical Cure at Day 21. Started May 2012; status: completed.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT01621399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01621399.